Table 2.
Region | Number at Risk of Infection, Millions | Number Infected, Millions | Number With Hydrocoele, Millions | Number With Lymphoedema, Millions | Annual Incidence of ADL Episode, Millions | DALY Burden, Millions | Average Economic Burden Per Chronic Case | Total Economic Burden, Millions |
---|---|---|---|---|---|---|---|---|
AFRO | 416.90 | 41.69 | 8.69 | 5.21 | 32.52 | 1.70 | $67.40 | $1148 |
EMRO | 23.83 | 2.38 | 0.50 | 0.30 | 1.86 | 0.10 | $145.87 | $134 |
PAHO | 8.87 | 0.89 | 0.18 | 0.11 | 0.69 | 0.04 | $111.85 | $40 |
SEARO | 789.98 | 79.00 | 16.46 | 9.87 | 61.62 | 3.22 | $135.47 | $4137 |
WPRO | 47.04 | 4.70 | 0.98 | 0.59 | 3.67 | 0.19 | $169.53 | $307 |
Total | 1286.62 | 128.66 | 26.80 | 16.08 | 100.36 | 5.25 | $114.69 | $5765 |
Costs are in 2016 US$.Abbreviations: ADL, adenolymphangitis; AFRO, WHO African region; DALY, disability-adjusted life years; EMRO, WHO Eastern Mediterranean region; PAHO, WHO pan-American region; SEARO, WHO South-East Asian region; WHO, World Health Organization; WPRO, WHO Western Pacific region.